Replies to post #2063 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA EDP-235 vs competition—for those too lazy to scroll through the slides :- )

$ENTA $AVIR $PFE $MRK $GILD https://t.co/Wax5QGU8NK pic.twitter.com/gNYZITkISK

— M (@bio_clouseau) October 19, 2021

[DewDiligence]

ENTA new corporate slide set—updated for discontinuation of EDP-721 (HBV RNA destabilizer)—also new slide #19 with in vitro data on COVID protease inhibitor EDP-235:

https://s22.q4cdn.com/306858242/files/doc_presentations/2021/11/Enanta-Corporate-Presentation-Final-11-18-21.pdf

Note: The new slide #19 is different from #19 in the previous version of the slide set, which also coincidentally had new data on EDP-235.